Dudeja, L., Janakiraman, A., Dudeja, I., Sane, K., & Babu, M. (2019). Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis. Indian J Ophthalmol.
Citação norma ChicagoDudeja, Lakshey, Anuja Janakiraman, Ishani Dudeja, Kaustubh Sane, and Manohar Babu. "Observer-masked Trial Comparing Efficacy of Topical Olopatadine (0.1%), Bepotastine (1.5%), and Alcaftadine (0.25%) in Mild to Moderate Allergic Conjunctivitis." Indian J Ophthalmol 2019.
Citação norma MLADudeja, Lakshey, et al. "Observer-masked Trial Comparing Efficacy of Topical Olopatadine (0.1%), Bepotastine (1.5%), and Alcaftadine (0.25%) in Mild to Moderate Allergic Conjunctivitis." Indian J Ophthalmol 2019.